Redcare Pharmacy N.V.
· ISIN: NL0012044747
· EQS - Company News
Redcare successfully executes placement of new convertible bonds and buys back part of the outstanding convertible bonds.
Corporate Insights - Short Sales, Director's Dealings, Sentiment Indicators - THE info hub for the informed investor
Smart tools for smart investors can be found in our Tools section
Corporate News Redcare Pharmacy N.V.
In this overview you can view company news in the chronological order of publication. The source information comes from EQS News, the leading European news distributor. The most recent news item is listed first.
This might be interesting for you as well
08 April 2025 11:45PM
Redcare successfully executes placement of new convertible bonds and buys back part of the outstanding convertible bonds.
THIS ANNOUNCEMENT, INCLUDING THE INFORMATION INCLUDED HEREIN, IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH, OR TO PERSONS IN ANY JURISDICTION TO WHOM, SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOUL...
Redcare Pharmacy N.V.
08 April 2025 11:21PM
Redcare Pharmacy N.V. successfully places EUR 300 million convertible bonds and repurchases part of its outstanding EUR 225 million 0.00% convertible bonds due 2028
THIS ANNOUNCEMENT, INCLUDING THE INFORMATION INCLUDED HEREIN, IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH, OR TO PERSONS IN ANY JURISDICTION TO WHOM, SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOUL...
Redcare Pharmacy N.V.
08 April 2025 05:49PM
Redcare Pharmacy N.V. launches EUR 300m convertible bonds and invites holders of its outstanding EUR 225m convertible bonds due 2028 to tender their bonds for cash
THIS ANNOUNCEMENT, INCLUDING THE INFORMATION INCLUDED HEREIN, IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH, OR TO PERSONS IN ANY JURISDICTION TO WHOM, SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOUL...
Redcare Pharmacy N.V.
04 April 2025 07:30AM
fast growth continues in Q1; fully-organic sales growth 28%, Rx sales in Germany up 191% and active customers up 0.6 million.
Redcare Pharmacy: fast growth continues in Q1; fully-organic sales growth 28%, Rx sales in Germany up 191% and active customers up 0.6 million.
Group sales up 28% or EUR 157M year over year, to EUR 717M in Q1.
Rx sales in Germany up 191% to EUR 108M.
Non-Rx sales up 20% to EUR 484M.
Active customer base up 0.6M in Q1 to 13.1M, 1.9M higher in ...
Redcare Pharmacy N.V.
02 April 2025 08:00AM
Michael Köhler and Stephan Weber nominated for the Supervisory Board of Redcare Pharmacy.
Michael Köhler and Stephan Weber nominated for the Supervisory Board of Redcare Pharmacy.
Sevenum, 2 April 2025. At Redcare Pharmacy’s upcoming Annual General Meeting (AGM) on 15 May 2025, changes to the composition of the Supervisory Board will be on the agenda. Redcare Pharmacy nominates the company’s founders and former board members Michael Kö...
Redcare Pharmacy N.V.
11 March 2025 06:30AM
Building on a successful 2024, Redcare Pharmacy expects margin uplift and unabated fast growth in 2025, including a doubling of Rx.
Building on a successful 2024, Redcare Pharmacy expects margin uplift and unabated fast growth in 2025, including a doubling of Rx.
Total sales +32% to EUR 2.4 bn in FY 2024 (Q4, +27%), with DACH +33% (Q4, 27%) and International +26% (Q4, 29%). Non-Rx sales +21% to EUR 1.6 bn (Q4, +22%).
Record gain in active customers, up 1.7M to 12.5M, with Ger...
Redcare Pharmacy N.V.
27 February 2025 12:15PM
Positive judgment of the European Court of Justice strengthens the position of Redcare Pharmacy and its customers.
Positive judgment of the European Court of Justice strengthens the position of Redcare Pharmacy and its customers.
Sevenum, the Netherlands, 27 February 2025 – Redcare Pharmacy welcomes today's judgment of the European Court of Justice that advertising measures that promote the purchase of prescription medicines in the form of direct discounts or...
Redcare Pharmacy N.V.
09 January 2025 06:45AM
2024 sales up 32% to EUR 2.4bn, with Rx growth in Germany accelerating to 142% in Q4.
Redcare Pharmacy completes an exceptional year across the Group: 2024 sales up 32% to EUR 2.4bn, with Rx growth in Germany accelerating to 142% in Q4.
Full-year sales increase 32% year over year to EUR 2.4bn; 21% growth in non-Rx sales to EUR 1.6bn and 64% growth in total Group Rx sales to EUR 749M.
In Q4, total sales rise 27% to EUR 674M; non-...
Redcare Pharmacy N.V.
05 November 2024 06:30AM
strong Q3 growth combined with 2% adj. EBITDA margin. Rx momentum in Germany further increased, with sales growth of over 130% in October.
Redcare Pharmacy: strong Q3 growth combined with 2% adj. EBITDA margin. Rx momentum in Germany further increased, with sales growth of over 130% in October.
Total Group sales growth 21% in Q3 to EUR 575M and 34% year to date to EUR 1.7bn after nine months.
Non-Rx sales growth 20% in Q3 to EUR 383M (9M growth 20% to EUR 1.2bn); Rx sales growth 23%...
Redcare Pharmacy N.V.
03 October 2024 10:01PM
Redcare Pharmacy achieves 81% growth in Q3 Rx sales in Germany, 108% in September and decides to accelerate marketing based on very convincing e-Rx metrics.
Redcare Pharmacy achieves 81% growth in Q3 Rx sales in Germany, 108% in September and decides to accelerate marketing based on very convincing e-Rx metrics.
Q3 total Group sales up 21% year over year to EUR 574M and year to date 34% to EUR 1.7bn; non-Rx sales growth 20% year over year to EUR 383M and also 20% year to date to EUR 1.2bn.
Active cus...
Redcare Pharmacy N.V.
03 October 2024 09:57PM
Redcare Pharmacy achieves 81% growth in Q3 Rx sales in Germany, 108% in September and decides to accelerate marketing in Q4 based on very convincing e-Rx metrics. Full-year guidance updated.
Redcare Pharmacy achieves 81% growth in Q3 Rx sales in Germany, 108% in September and decides to accelerate marketing in Q4 based on very convincing e-Rx metrics. Full-year guidance updated.
Sevenum, the Netherlands, 3 October 2024. The Management Board of Redcare Pharmacy has decided to intensify marketing investments for its e-Rx business in Ger...
Redcare Pharmacy N.V.
30 July 2024 06:30AM
Redcare Pharmacy achieves rapid increase of Rx sales in Germany, continues its strong double-digit overall growth rate and closes Q2 with a solid 2.7% margin.
Redcare Pharmacy achieves rapid increase of Rx sales in Germany, continues its strong double-digit overall growth rate and closes Q2 with a solid 2.7% margin.
Total sales of over EUR 1.1 bn after six months, up 42%, with Q2 year-over-year growth of 34% to EUR 561M.
H1 non-Rx sales of EUR 795M (+20%); EUR 391M in Q2 (+21%).
Total Rx sales of EUR...
Redcare Pharmacy N.V.
04 July 2024 06:45AM
Strong acceleration of e-Rx sales in Germany for Redcare Pharmacy, from 7% growth in Q1 to 37% in Q2.
Strong acceleration of e-Rx sales in Germany for Redcare Pharmacy, from 7% growth in Q1 to 37% in Q2.
Total sales reached EUR 560M in Q2, up 33% year over year.
Non-Rx sales totaled EUR 390M, steady continuation of fast growth, up 21% year over year.
Rx sales increased to EUR 50M in Germany, 37% growth in Q2 year over year, while CardLink was la...
Redcare Pharmacy N.V.
06 May 2024 04:57PM
the convenient way to redeem e-prescriptions from anywhere.
Redcare Pharmacy's eHealth-CardLink solution has just been launched: the convenient way to redeem e-prescriptions from anywhere.
Fully digital redemption method via eGK health card and smartphone.
Secure, easy and comfortable way to redeem e-prescriptions.
Technically integrated within Redcare’s Shop Apotheke mobile app in Germany.
Sevenum, the ...
Redcare Pharmacy N.V.
25 April 2024 06:30AM
Redcare’s fast double-digit growth continues in Q1, and at a 2.1% positive margin. Also in Q1, after many years, breakthrough in online e-Rx in Germany.
Redcare’s fast double-digit growth continues in Q1, and at a 2.1% positive margin. Also in Q1, after many years, breakthrough in online e-Rx in Germany.
Group sales of EUR 560M in Q1, up 51% from prior year.
Non-Rx sales growth 20% to EUR 404M; Rx sales up 7% in Germany, following additional marketing and communication campaigns.
Adj. EBITDA ma...
Redcare Pharmacy N.V.
23 April 2024 03:59PM
Redcare Pharmacy’s eHealth-CardLink solution approved by gematik today.
Redcare Pharmacy’s eHealth-CardLink solution approved by gematik today.
Fully digital redemption method to be integrated in Redcare’s Shop Apotheke mobile app in Germany.
Expected to be available for customers by early May.
Redcare ideally positioned to serve e-Rx customers in the multi-billion-euro German prescription market.
Sevenum, the Neth...
Redcare Pharmacy N.V.
23 April 2024 03:56PM
Redcare Pharmacy’s eHealth-CardLink solution approved by gematik today.
Redcare Pharmacy’s eHealth-CardLink solution approved by gematik today.
Today, Redcare Pharmacy has received approval to implement its eHealth-CardLink solution from the German national agency for digital medicine, gematik. This will enable Redcare Pharmacy to offer patients in Germany a user-friendly method to redeem e-prescriptions by using thei...
Redcare Pharmacy N.V.
18 April 2024 09:00AM
Redcare Pharmacy's Annual General Meeting 2024 approved all agenda items. Dirk Brüse and Lode Fastré new members of the Managing Board.
Redcare Pharmacy's Annual General Meeting 2024 approved all agenda items. Dirk Brüse and Lode Fastré new members of the Managing Board.
Sevenum, the Netherlands, 18 April, 2024. At Redcare Pharmacy’s Annual General Meeting held yesterday, shareholders voted with an absolute majority for all agenda items, among others the appointment of Dirk Brüse ...
Redcare Pharmacy N.V.
04 April 2024 06:45AM
Strong start of the year for Redcare Pharmacy, double-digit sales growth continues.
Strong start of the year for Redcare Pharmacy, double-digit sales growth continues.
Total sales growth 51% year over year to EUR 560M in Q1 and 19% excluding MediService.
Non-Rx sales growth 20% to EUR 404M.
Active customer base expanded to 11.2M, up 0.4M in Q1 and 1.5M year over year.
Net promoter score remained unabatedly high around 70.
Fi...
Redcare Pharmacy N.V.
05 March 2024 06:30AM
growth 49%, adj. EBITDA margin up 3.7pp to 3%; guidance achieved in all its elements.
Successful completion of a record year for Redcare Pharmacy: growth 49%, adj. EBITDA margin up 3.7pp to 3%; guidance achieved in all its elements.
Total Group sales EUR 1.8 bn, up 49% vs. prior year.
Non-Rx sales EUR 1.3 bn, up 25% vs. prior year.
Adj. EBITDA margin 3% for full year 2023, +3.7pp vs. 2022, with major improvements in both DACH an...
Redcare Pharmacy N.V.
04 March 2024 07:04PM
Redcare Pharmacy with internal succession plan for Stephan Weber (CCO) and Marc Fischer (CIO).
Seamless transition for continuity and stability: Redcare Pharmacy with internal succession plan for Stephan Weber (CCO) and Marc Fischer (CIO).
Dirk Brüse and Lode Fastré, both long-standing managers at Redcare Pharmacy, are to succeed Stephan Weber and Marc Fischer as CCO and CIO.
Board members and founders see the ideal time for the leadership...
Redcare Pharmacy N.V.
04 March 2024 07:02PM
Redcare Pharmacy with internal succession plan due to the early departure of CCO Stephan Weber and CIO Marc Fischer at the Annual General Meeting on 17 April 2024.
Disclosure of inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014
Redcare Pharmacy with internal succession plan due to the early departure of CCO Stephan Weber and CIO Marc Fischer at the Annual General Meeting on 17 April 2024.
Sevenum, 4 March 2024. The Supervisory Board of Redcare Pharmacy today has agreed to the e...
Redcare Pharmacy N.V.
10 January 2024 06:45AM
Another successful fast-growth quarter for Redcare Pharmacy, completing full year 2023 at the very upper end of its guidance.
Another successful fast-growth quarter for Redcare Pharmacy, completing full year 2023 at the very upper end of its guidance.
Q4 total sales EUR 531M, year-over-year growth 62%, excluding MediService 23%.
Full year total sales EUR 1.8bn vs. guidance of EUR 1.7-1.8bn, a growth of 49%. Excluding MediService, growth was 24%.
Non-Rx sales grew 23% ...
Redcare Pharmacy N.V.
31 October 2023 06:30AM
continued very fast growth combined with major margin lift; adj. EBITDA 3.2% in Q3, vs. 0.4% last year.
Redcare Pharmacy: continued very fast growth combined with major margin lift; adj. EBITDA 3.2% in Q3, vs. 0.4% last year.
Group sales up 67% to EUR 476M in Q3 (9M up 45% to EUR 1.3bn).
Non-Rx sales growth 27% in Q3 to EUR 319M (9M up 26% to EUR 979M).
MediService performing on plan; full-year outlook confirmed.
Adj. EBITDA margin 3.2% in Q3 (9M...
Redcare Pharmacy N.V.
05 October 2023 06:45AM
Redcare Pharmacy continues to successfully grow fast in all its markets.
Redcare Pharmacy continues to successfully grow fast in all its markets.
Total sales growth 67% in Q3, to EUR 475M.
Year-to-date total sales growth 45%, to EUR 1.3bn.
Organic growth (i.e. excluding sales of MediService) 26% to EUR 358M in Q3 and 24% to EUR 1.1bn year to date.
Non-Rx growth 27% in Q3 (to EUR 319M) and year to date 26% (to EUR 97...
Redcare Pharmacy N.V.
01 August 2023 06:30AM
While fast sales growth continues unabated at 46%, adj. EBITDA margin improved 5.3pp year over year to 3.2%. Company raises full-year guidance.
Redcare Pharmacy Q2 2023: While fast sales growth continues unabated at 46%, adj. EBITDA margin improved 5.3pp year over year to 3.2%. Company raises full-year guidance.
Total sales up 46% in Q2 to EUR 420M and by 34% in H1 to EUR 792M.
Excluding MediService AG (consolidated since mid-May), sales up 25% in Q2 and 24% in H1.
Non-Rx growth 27% in ...
Redcare Pharmacy N.V.
01 August 2023 06:30AM
Redcare Pharmacy Q2 2023: While fast sales growth continues unabated at 46%, adj. EBITDA margin improved 5.3pp year over year to 3.2%. Company raises full-year guidance.
Redcare Pharmacy Q2 2023: While fast sales growth continues unabated at 46%, adj. EBITDA margin improved 5.3pp year over year to 3.2%. Company raises full-year guidance.
Total sales up 46% in Q2 to EUR 420M and by 34% in H1 to EUR 792M.
Excluding MediService AG (consolidated since mid-May), sales up 25% in Q2 and 24% in H1.
Non-Rx growth 27% in ...
Redcare Pharmacy N.V.
06 July 2023 06:45AM
Very successful quarter for Redcare Pharmacy N.V. with a further acceleration in sales growth.
Very successful quarter for Redcare Pharmacy N.V. with a further acceleration in sales growth.
Total sales growth 47% to EUR 421M in Q2.
Year to date sales EUR 793M, a growth of 34%.
Excluding the sales of MediService AG (transaction with Galenica AG completed mid-May), sales growth was 26% to EUR 361M in Q2 and 24% to EUR 733M year to date, dri...
Redcare Pharmacy N.V.
06 July 2023 06:45AM
Very successful quarter for Redcare Pharmacy N.V. with a further acceleration in sales growth.
Very successful quarter for Redcare Pharmacy N.V. with a further acceleration in sales growth.
Total sales growth 47% to EUR 421M in Q2.
Year to date sales EUR 793M, a growth of 34%.
Excluding the sales of MediService AG (transaction with Galenica AG completed mid-May), sales growth was 26% to EUR 361M in Q2 and 24% to EUR 733M year to date, dri...
Redcare Pharmacy N.V.
13 June 2023 09:32AM
Official ticker-symbol change on the Frankfurt Stock Exchange and the new corporate site launch today.
Sevenum, the Netherlands, 13 June 2023. As part of its rebranding, Europe’s leadinge-pharmacy changed its ticker symbol on the stock exchange from SAE to RDC. Following this, and the simultaneous launch of the new corporate website, the corporate rebranding is now official.
With today’s event, Europe’s largest one-stop pharmacy takes another step ...
Redcare Pharmacy N.V.
13 June 2023 09:32AM
Welcome, Redcare Pharmacy: Official ticker-symbol change on the Frankfurt Stock Exchange and the new corporate site launch today.
Sevenum, the Netherlands, 13 June 2023. As part of its rebranding, Europe’s leadinge-pharmacy changed its ticker symbol on the stock exchange from SAE to RDC. Following this, and the simultaneous launch of the new corporate website, the corporate rebranding is now official.
With today’s event, Europe’s largest one-stop pharmacy takes another step ...
Redcare Pharmacy N.V.
06 June 2023 09:15AM
SHOP APOTHEKE EUROPE PROMOTED TO THE MDAX.
SHOP APOTHEKE EUROPE PROMOTED TO THE MDAX.
Sevenum, the Netherlands, 6 June 2023. SHOP APOTHEKE EUROPE will be promoted to the MDAX, the leading German stock index for mid-sized companies, following the latest index review by global index provider STOXX Ltd.
Effective 19 June 2023, SHOP APOTHEKE EUROPE will be among the 50 largest listed companie...
Redcare Pharmacy N.V.
06 June 2023 09:15AM
SHOP APOTHEKE EUROPE PROMOTED TO THE MDAX.
SHOP APOTHEKE EUROPE PROMOTED TO THE MDAX.
Sevenum, the Netherlands, 6 June 2023. SHOP APOTHEKE EUROPE will be promoted to the MDAX, the leading German stock index for mid-sized companies, following the latest index review by global index provider STOXX Ltd.
Effective 19 June 2023, SHOP APOTHEKE EUROPE will be among the 50 largest listed companie...
Redcare Pharmacy N.V.
22 May 2023 10:59PM
Termination of voting pool agreement.
Redcare Pharmacy N.V. (formerly SHOP APOTHEKE EUROPE N.V.): Termination of voting pool agreement.
Sevenum, the Netherlands, 22 May 2023. Redcare Pharmacy N.V. (formerly SHOP APOTHEKE EUROPE N.V.) has been informed today that the pool agreement of 25 individual shareholders, who at the time of its formation controlled more than 26% of the voting rig...
SHOP APOTHEKE EUROPE N.V.
22 May 2023 10:59PM
Redcare Pharmacy N.V. (formerly SHOP APOTHEKE EUROPE N.V.): Termination of voting pool agreement.
Redcare Pharmacy N.V. (formerly SHOP APOTHEKE EUROPE N.V.): Termination of voting pool agreement.
Sevenum, the Netherlands, 22 May 2023. Redcare Pharmacy N.V. (formerly SHOP APOTHEKE EUROPE N.V.) has been informed today that the pool agreement of 25 individual shareholders, who at the time of its formation controlled more than 26% of the voting rig...
SHOP APOTHEKE EUROPE N.V.
11 May 2023 07:18PM
SHOP APOTHEKE EUROPE and Galenica Create the Leading Online Pharmacy in Switzerland.
Joint Venture Approved: SHOP APOTHEKE EUROPE and Galenica Create the Leading Online Pharmacy in Switzerland.
Sevenum, the Netherlands, 11 May 2023. The competition authorities in Switzerland and Austria confirmed the approval for the joint venture between SHOP APOTHEKE EUROPE and Galenica today.
In late March 2023, SHOP APOTHEKE EUROPE, Europe’s ...
SHOP APOTHEKE EUROPE N.V.
11 May 2023 07:18PM
Joint Venture Approved: SHOP APOTHEKE EUROPE and Galenica Create the Leading Online Pharmacy in Switzerland.
Joint Venture Approved: SHOP APOTHEKE EUROPE and Galenica Create the Leading Online Pharmacy in Switzerland.
Sevenum, the Netherlands, 11 May 2023. The competition authorities in Switzerland and Austria confirmed the approval for the joint venture between SHOP APOTHEKE EUROPE and Galenica today.
In late March 2023, SHOP APOTHEKE EUROPE, Europe’s ...
SHOP APOTHEKE EUROPE N.V.
11 May 2023 07:14PM
Antitrust clearances for joint venture granted
SHOP APOTHEKE EUROPE and GALENICA: Antitrust clearances for joint venture granted
Sevenum, the Netherlands, 11 May 2023 Redcare Pharmacy N.V. (formerly SHOP APOTHEKE EUROPE N.V.) and GALENICA AG announce that they have received clearances from the relevant antitrust authorities for the incorporation of their announced joint venture in the Swiss ma...
SHOP APOTHEKE EUROPE N.V.
11 May 2023 07:14PM
SHOP APOTHEKE EUROPE and GALENICA: Antitrust clearances for joint venture granted
SHOP APOTHEKE EUROPE and GALENICA: Antitrust clearances for joint venture granted
Sevenum, the Netherlands, 11 May 2023 Redcare Pharmacy N.V. (formerly SHOP APOTHEKE EUROPE N.V.) and GALENICA AG announce that they have received clearances from the relevant antitrust authorities for the incorporation of their announced joint venture in the Swiss ma...
SHOP APOTHEKE EUROPE N.V.
02 May 2023 06:45AM
SHOP APOTHEKE EUROPE: STRONG Q1 WITH 22% SALES GROWTH AND EBITDA MARGIN IN UPPER PART OF FULL-YEAR GUIDANCE.
SHOP APOTHEKE EUROPE: STRONG Q1 WITH 22% SALES GROWTH AND EBITDA MARGIN IN UPPER PART OF FULL-YEAR GUIDANCE.
Total sales up 22% to EUR 372 million.
Non-Rx sales growth 23%; outpacing the full-year guidance of 10 to 20%.
Adj. EBITDA margin 2.4%, 3.8 pp better than Q1 2022; upper part of the full-year guidance of 0.5 to 2.5%.
Comfortably on tra...
SHOP APOTHEKE EUROPE N.V.
02 May 2023 06:45AM
STRONG Q1 WITH 22% SALES GROWTH AND EBITDA MARGIN IN UPPER PART OF FULL-YEAR GUIDANCE.
SHOP APOTHEKE EUROPE: STRONG Q1 WITH 22% SALES GROWTH AND EBITDA MARGIN IN UPPER PART OF FULL-YEAR GUIDANCE.
Total sales up 22% to EUR 372 million.
Non-Rx sales growth 23%; outpacing the full-year guidance of 10 to 20%.
Adj. EBITDA margin 2.4%, 3.8 pp better than Q1 2022; upper part of the full-year guidance of 0.5 to 2.5%.
Comfortably on tra...
SHOP APOTHEKE EUROPE N.V.
27 April 2023 10:11AM
Approval of New CEO and Change of Corporate Name.
Successful Outcome of SHOP APOTHEKE EUROPE's Annual General Meeting 2023: Approval of New CEO and Change of Corporate Name.
Sevenum, the Netherlands, 27 April 2023. Yesterday's Annual General Meeting of SHOP APOTHEKE EUROPE N.V. was a resounding success - investors voted with an absolute majority in favour of both the appointment of Olaf Heinrich ...
SHOP APOTHEKE EUROPE N.V.
27 April 2023 10:11AM
Successful Outcome for SHOP APOTHEKE EUROPE's Annual General Meeting 2023: Approval of New CEO and Change of Corporate Name.
Successful Outcome of SHOP APOTHEKE EUROPE's Annual General Meeting 2023: Approval of New CEO and Change of Corporate Name.
Sevenum, the Netherlands, 27 April 2023. Yesterday's Annual General Meeting of SHOP APOTHEKE EUROPE N.V. was a resounding success - investors voted with an absolute majority in favour of both the appointment of Olaf Heinrich ...
SHOP APOTHEKE EUROPE N.V.
05 April 2023 06:45AM
SHOP APOTHEKE EUROPE: VERY STRONG START TO YEAR, FASTEST GROWTH SINCE EARLY 2021.
SHOP APOTHEKE EUROPE: VERY STRONG START TO YEAR, FASTEST GROWTH SINCE EARLY 2021.
Q1 total sales up 22% year over year to EUR 371 million.
Non-Rx sales growth 23%.
Customer satisfaction remains very high with NPS above 70.
Continued fast growth of customer base to 9.7 million; active customer base up 0.4 million in Q1 and 1.4 million year over ...
SHOP APOTHEKE EUROPE N.V.
05 April 2023 06:45AM
VERY STRONG START TO YEAR, FASTEST GROWTH SINCE EARLY 2021.
SHOP APOTHEKE EUROPE: VERY STRONG START TO YEAR, FASTEST GROWTH SINCE EARLY 2021.
Q1 total sales up 22% year over year to EUR 371 million.
Non-Rx sales growth 23%.
Customer satisfaction remains very high with NPS above 70.
Continued fast growth of customer base to 9.7 million; active customer base up 0.4 million in Q1 and 1.4 million year over ...
SHOP APOTHEKE EUROPE N.V.
30 March 2023 06:59AM
SHOP APOTHEKE EUROPE and GALENICA enter into a strategic partnership and jointly establish the leading online pharmacy in Switzerland.
SHOP APOTHEKE EUROPE and GALENICA enter into a strategic partnership and jointly establish the leading online pharmacy in Switzerland.
Sevenum, the Netherlands, 30 March 2023. As part of a strategic partnership, Europe's leading e-pharmacy SHOP APOTHEKE EUROPE N.V. and GALENICA AG, the leading integrated healthcare provider in Switzerland, are ...
SHOP APOTHEKE EUROPE N.V.
30 March 2023 06:59AM
SHOP APOTHEKE EUROPE and GALENICA enter into a strategic partnership and jointly establish the leading online pharmacy in Switzerland.
SHOP APOTHEKE EUROPE and GALENICA enter into a strategic partnership and jointly establish the leading online pharmacy in Switzerland.
Sevenum, the Netherlands, 30 March 2023. As part of a strategic partnership, Europe's leading e-pharmacy SHOP APOTHEKE EUROPE N.V. and GALENICA AG, the leading integrated healthcare provider in Switzerland, are ...
SHOP APOTHEKE EUROPE N.V.
30 March 2023 06:58AM
SHOP APOTHEKE EUROPE N.V. and GALENICA AG enter into strategic partnership and establish a joint venture for the Swiss business; execution of capital increase.
SHOP APOTHEKE EUROPE N.V. and GALENICA AG enter into strategic partnership and establish a joint venture for the Swiss business; execution of capital increase.
Sevenum, 30 March 2023. SHOP APOTHEKE EUROPE N.V. ("SHOP APOTHEKE EUROPE") and the internationally active Swiss integrated healthcare service provider GALENICA AG, operating in the segme...
SHOP APOTHEKE EUROPE N.V.
More Redcare Pharmacy N.V. related information
| Type | Total | Last | Made by | Go to |
|---|---|---|---|---|
| Corporate Research | 0 | - | - | Corporate Research |
| Directors Dealings | 14 | 18th March 2025 | Holler, Theresa Margarete | DD |
| Short Seller (DE) | 57 | 23rd April 2025 | AHL Partners LLP | SSR (DE) |
| Short Seller (UK) | 0 | - | - | SSR (UK) |
Disclaimer:
The combination of information with graphic elements makes an important contribution to visual orientation and navigation through complex factual topics. Essential content features can be perceived, grasped and contextually processed much faster.
The figurative marks, logos and other graphic and textual elements used on this website are for illustrative purposes only. All rights to the aforementioned elements are held by their respective owners. They are used without the intention of copyright infringement or intellectual property infringement.
If you believe that copyrights or intellectual property have been infringed by the choice of illustration, please contact us immediately to clarify the issue.
v.07062023 EN